MX2009006346A - Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos. - Google Patents

Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos.

Info

Publication number
MX2009006346A
MX2009006346A MX2009006346A MX2009006346A MX2009006346A MX 2009006346 A MX2009006346 A MX 2009006346A MX 2009006346 A MX2009006346 A MX 2009006346A MX 2009006346 A MX2009006346 A MX 2009006346A MX 2009006346 A MX2009006346 A MX 2009006346A
Authority
MX
Mexico
Prior art keywords
ethinylxanthine
selective
derivatives
receptor antagonists
dopamine
Prior art date
Application number
MX2009006346A
Other languages
English (en)
Inventor
Christa Mueller
Joerg Hockenmeyer
Nikolay Tzvetkov
Joachim Burbiel
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41294864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009006346(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06026739A external-priority patent/EP1939197A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of MX2009006346A publication Critical patent/MX2009006346A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se revelan compuestos novedosos de la fórmula general (la) y sus sales, isómeros, diastereómeros o enantiómeros de los mismos farmacéuticamente aceptables (la) (ver fórmula (Ia)) y su uso como medicamentos, por ejemplo, en el tratamiento de trastornos del movimiento relacionados con dopamina.
MX2009006346A 2006-12-22 2007-12-19 Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos. MX2009006346A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06026739A EP1939197A1 (en) 2006-12-22 2006-12-22 8-ethinylxanthine derivatives as selective A2A receptor antagonists
US94524807P 2007-06-20 2007-06-20
PCT/EP2007/011172 WO2008077557A1 (en) 2006-12-22 2007-12-19 8-ethinylxanthine derivatives as selective a2a receptor antagonists

Publications (1)

Publication Number Publication Date
MX2009006346A true MX2009006346A (es) 2010-03-03

Family

ID=41294864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006346A MX2009006346A (es) 2006-12-22 2007-12-19 Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos.

Country Status (7)

Country Link
JP (1) JP2010513353A (es)
KR (1) KR20090094465A (es)
CL (1) CL2007003778A1 (es)
DO (1) DOP2009000145A (es)
MX (1) MX2009006346A (es)
PE (1) PE20081543A1 (es)
TW (1) TW200848421A (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992006976A1 (fr) * 1990-10-18 1992-04-30 Kyowa Hakko Kogyo Co., Ltd. Derive de xanthine
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US5703085A (en) * 1994-02-23 1997-12-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives

Also Published As

Publication number Publication date
KR20090094465A (ko) 2009-09-07
JP2010513353A (ja) 2010-04-30
TW200848421A (en) 2008-12-16
PE20081543A1 (es) 2009-01-04
CL2007003778A1 (es) 2009-03-27
DOP2009000145A (es) 2009-07-15

Similar Documents

Publication Publication Date Title
WO2008077557A8 (en) 8-ethinylxanthine derivatives as selective a2a receptor antagonists
EA017278B9 (ru) Соединения азаиндазола и способы применения
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
NO20084129L (no) Pyridin(3,4-B)Pyrazinoner
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2008012622A3 (en) Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
MX2009004662A (es) Compuestos de pirazolina como antagonistas receptores de mineralocorticoides.
MX2012004848A (es) Compuestos heterociclicos triciclicos.
MX2009000169A (es) Derivados de purinona como agonistas de hm74a.
GEP20125538B (en) 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous system diseases
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
PL1807434T3 (pl) Tienopirydyny jako allosteryczne środki wzmacniające receptor M4 muskarynowy
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
MX2007006387A (es) Derivados de piridina 3-substituidos como antagonistas h3.
MY149854A (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
MX2010006230A (es) Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3.
DE602006018713D1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
ATE496918T1 (de) Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate
MX2009013501A (es) Compuestos piperidinicos y sus usos.
JO3319B1 (ar) مركبات 3- (ايميدازول) - بيرازولو (3,4 - b ) بيريدين
NO20080033L (no) Kinolinderivater som NK3-antagonister
ZA200709090B (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
ZA200709094B (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
NO20065551L (no) Anvendelse av opoid reseptor antagonistforbindelser for forhindring og/eller behandling av sykdommer assosiert med malet calcineurin
ZA200709096B (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility

Legal Events

Date Code Title Description
FA Abandonment or withdrawal